HK1218139A1 - 去分化的重新編程細胞所衍生的細胞組合物 - Google Patents

去分化的重新編程細胞所衍生的細胞組合物 Download PDF

Info

Publication number
HK1218139A1
HK1218139A1 HK16106057.9A HK16106057A HK1218139A1 HK 1218139 A1 HK1218139 A1 HK 1218139A1 HK 16106057 A HK16106057 A HK 16106057A HK 1218139 A1 HK1218139 A1 HK 1218139A1
Authority
HK
Hong Kong
Prior art keywords
cell compositions
reprogrammed cells
compositions derived
cell culture
dedifferentiated reprogrammed
Prior art date
Application number
HK16106057.9A
Other languages
English (en)
Chinese (zh)
Inventor
Alan D. Agulnick
Olivia Kelly
Yuki OHI
Allan Robins
Thomas Schultz
Original Assignee
Viacyte, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/761,078 external-priority patent/US9109245B2/en
Application filed by Viacyte, Inc. filed Critical Viacyte, Inc.
Publication of HK1218139A1 publication Critical patent/HK1218139A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0012—Cell encapsulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0676—Pancreatic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK16106057.9A 2013-02-06 2014-02-06 去分化的重新編程細胞所衍生的細胞組合物 HK1218139A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/761,078 US9109245B2 (en) 2009-04-22 2013-02-06 Cell compositions derived from dedifferentiated reprogrammed cells
US13/761,078 2013-02-06
PCT/US2014/015156 WO2014124172A1 (en) 2013-02-06 2014-02-06 Cell compositions derived from dedifferentiated reprogrammed cells

Publications (1)

Publication Number Publication Date
HK1218139A1 true HK1218139A1 (zh) 2017-02-03

Family

ID=50239931

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16106057.9A HK1218139A1 (zh) 2013-02-06 2014-02-06 去分化的重新編程細胞所衍生的細胞組合物

Country Status (8)

Country Link
EP (1) EP2954045A1 (enrdf_load_stackoverflow)
JP (5) JP6517702B2 (enrdf_load_stackoverflow)
AU (4) AU2014214879A1 (enrdf_load_stackoverflow)
CA (2) CA2898431C (enrdf_load_stackoverflow)
HK (1) HK1218139A1 (enrdf_load_stackoverflow)
IL (5) IL290717B2 (enrdf_load_stackoverflow)
RU (2) RU2675928C2 (enrdf_load_stackoverflow)
WO (1) WO2014124172A1 (enrdf_load_stackoverflow)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9109245B2 (en) 2009-04-22 2015-08-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
US10655105B2 (en) 2014-08-04 2020-05-19 Takeda Pharmaceutical Company Limited Method for proliferation of pancreatic progenitor cells
MA45479A (fr) * 2016-04-14 2019-02-20 Janssen Biotech Inc Différenciation de cellules souches pluripotentes en cellules de l'endoderme de l'intestin moyen
CN111334463B (zh) * 2016-05-18 2024-02-20 学校法人庆应义塾 类器官培养用细胞培养基、培养方法及类器官
WO2018139600A1 (ja) 2017-01-27 2018-08-02 株式会社カネカ 内胚葉系細胞集団、及び多能性細胞から三胚葉のいずれかの細胞集団を製造する方法
CA3066055A1 (en) 2017-06-14 2018-12-20 Semma Therapeutics, Inc. Devices and methods for delivering therapeutics
EP3654996A4 (en) * 2017-07-21 2021-03-24 Semma Therapeutics, Inc. REAGGREGATION OF PANCREAS BETA CELLS FROM STEM CELLS
AU2019313964A1 (en) * 2018-08-03 2021-03-18 Kyoto University Cell production method
MX2021003147A (es) * 2018-09-19 2021-05-14 Takeda Pharmaceuticals Co Celulas productoras de insulina.
JP2022535239A (ja) 2019-05-31 2022-08-05 ダブリュ．エル．ゴア アンド アソシエイツ，インコーポレイティド 生体適合性メンブレン複合体
US20220234006A1 (en) 2019-05-31 2022-07-28 W. L. Gore & Associates, Inc. A biocompatible membrane composite
WO2020243665A1 (en) 2019-05-31 2020-12-03 W. L. Gore & Associates, Inc. A biocompatible membrane composite
CA3139292A1 (en) 2019-05-31 2020-12-03 Timothy M. BRUHN Cell encapsulation devices with controlled oxygen diffusion distances
CA3186967A1 (en) 2020-07-31 2022-02-03 George Harb Differentiation of pancreatic endocrine cells

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4794049B2 (ja) * 1999-04-06 2011-10-12 ジェネンテック， インコーポレイテッド 糖尿病治療へのＥｒｂＢレセプターリガンドの使用
US6759039B2 (en) * 2000-06-30 2004-07-06 Amcyte, Inc. Culturing pancreatic stem cells having a specified, intermediate stage of development
JP2005503759A (ja) * 2001-01-24 2005-02-10 アメリカ合衆国 幹細胞の膵臓内分泌細胞への分化方法
AU2006304318B2 (en) * 2005-10-14 2012-12-06 Regents Of The University Of Minnesota Differentiation of non-embryonic stem cells to cells having a pancreatic phenotype
WO2007143193A1 (en) * 2006-06-02 2007-12-13 University Of Georgia Research Foundation, Inc. Pancreatic and liver endoderm cells and tissue by differentiation of definitive endoderm cells obtained from human embryonic stems
EP2356227B1 (en) 2008-11-14 2018-03-28 Viacyte, Inc. Encapsulation of pancreatic cells derived from human pluripotent stem cells
EP2421957B1 (en) * 2009-04-22 2020-11-18 Viacyte, Inc. Cell compositions derived from dedifferentiated reprogrammed cells
CN102741396B (zh) * 2009-04-27 2017-10-20 威盛细胞有限公司 支持多能细胞生长的小分子和其方法

Also Published As

Publication number Publication date
AU2022200075B2 (en) 2023-02-02
IL321825A (en) 2025-08-01
IL290717A (en) 2022-04-01
CA2898431A1 (en) 2014-08-14
JP2016506736A (ja) 2016-03-07
JP2019146578A (ja) 2019-09-05
RU2754089C2 (ru) 2021-08-26
IL311689A (en) 2024-05-01
IL290717B1 (en) 2024-06-01
CA2898431C (en) 2023-10-17
JP2025000625A (ja) 2025-01-07
IL239953A0 (en) 2015-08-31
JP2020178694A (ja) 2020-11-05
IL290717B2 (en) 2024-10-01
CA3212301A1 (en) 2014-08-14
AU2014214879A1 (en) 2015-07-30
JP7250731B2 (ja) 2023-04-03
IL311689B1 (en) 2025-08-01
JP6517702B2 (ja) 2019-05-22
RU2018144412A (ru) 2019-03-25
AU2019201314A1 (en) 2019-03-14
RU2675928C2 (ru) 2018-12-25
RU2015131279A (ru) 2017-03-13
JP6721752B2 (ja) 2020-07-15
JP7550830B2 (ja) 2024-09-13
IL239953B (en) 2021-05-31
IL283088A (en) 2021-06-30
IL283088B (en) 2022-04-01
JP2023017838A (ja) 2023-02-07
RU2018144412A3 (enrdf_load_stackoverflow) 2020-02-14
AU2022200075C1 (en) 2023-07-06
AU2022200075A1 (en) 2022-02-03
AU2023202507A1 (en) 2023-05-11
EP2954045A1 (en) 2015-12-16
AU2019201314B2 (en) 2021-10-14
WO2014124172A1 (en) 2014-08-14

Similar Documents

Publication Publication Date Title
HK1218139A1 (zh) 去分化的重新編程細胞所衍生的細胞組合物
IL273159A (en) A culture medium preparation, and a method for culturing cells or tissues by using the preparation
WO2010124142A3 (en) Cell compositions derived from dedifferentiated reprogrammed cells
MX375786B (es) Biosintesis microbiana de ergotioneina.
EP3344755A4 (en) PREPARATION SYSTEM FOR PLURIPOTENTE STEM CELLS AND METHOD FOR THE PRODUCTION OF INDUCED PLURIPOTENTAL STEM CELLS
WO2016012544A3 (en) Enhanced reprogramming to ips cells
UA118328C2 (uk) Спосіб інтегрування екзогенних послідовностей у геном рослинної клітини
WO2012006440A3 (en) Endothelial cell production by programming
WO2012051210A3 (en) Mesenchymal stem cells and related therapies
WO2011130402A3 (en) Hepatocyte production by forward programming
EP2904103B8 (en) Method for preparing induced pluripotent stem cells and its applications
EP3070163A4 (en) Method for preparing induced pluripotent stem cell, composition used in method, and uses thereof
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
MY170720A (en) Antibody formulations
EP3060650A4 (en) Culturing pluripotent stem cells
AU2013225816A8 (en) Compositions and methods for treating Type III Gaucher Disease
WO2012019002A3 (en) Somatic stem cells
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
EP3263697A4 (en) Culture medium for culturing mesenchymal stem cell, method for culturing mesenchymal stem cell, and mesenchymal stem cell
EP3048169A4 (en) Method for preparing pluripotent stem cells
WO2013188469A3 (en) Pathways characterization of cells
MX366112B (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
WO2014027176A3 (en) Stem cell culture method
HK1202375A1 (en) Skin lightening compositions
WO2013163297A8 (en) Modified glycoproteins